Our approach directly activates the skin cell’s existing DNA to transform it into a new, healthy egg cell. This avoids the challenges with traditional approaches to producing eggs and sperm in vitro.
Our goal is to give women confidence in their ability to choose whether and when to have a child—and in the long term, ensure that every person and couple has the choice to have genetic children, including same-sex couples.
Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 27, 2020 | Next-gen skincare, silk without spiders and pollution for lunch: Meet the biotech startups pitching at IndieBio’s Demo Day | Biotech can often, and sometimes literally, fly over our heads. However, the pandemic has shown an increased need for investment and focus on solutions that work on human and planetary health. For IndieBio, a science and biotech accelerator... |
Reviews 0
FAQ about Ivy Natal
When was Ivy Natal founded?
Ivy Natal was founded in 2020.
How much funding has Ivy Natal raised?
Ivy Natal has raised $250K in total across 1 funding round.
What has the press written about Ivy Natal?
Parsers VC has collected 2 articles mentioning Ivy Natal, among them “Next-gen skincare, silk without spiders and pollution for lunch: Meet the biotech startups pitching at IndieBio’s Demo Day” (Oct 27, 2020).
Is Ivy Natal still active?
Yes, Ivy Natal is active; its latest activity on Parsers VC dates from Oct 27, 2020.